April 23, 2018
Kissei Announces New President and COO
Kissei Pharmaceutical Co., Ltd.
At the meeting of our Company's Board of Directors on April 23, 2018, a decision was made to change the President as follows.
This change will be authorized at the regular shareholders' meeting and at the meeting of Board of Directors, both scheduled for June 27, 2018.
1.Reason for Change
Kissei reviews management structure to challenge to responding some issues arising from change of the business environment.
|New Title||Name||Current Title|
|President and COO||Yoshio Furihata||Managing Director,
Member of the board,
Head of Clinical Development Division
|Member of the board,
|Masaki Morozumi||President and COO|
3.Resume of the new President
January 12, 1962)
April 1984 Joined the Company
October 2000 Representative of Kissei Pharma Europe, Ltd.
April 2007 Director of Business Development
June 2008 Member of the board,
June 2010 Member of the board,
June 2012 Member of the board,
June 2016 Managing Director,
4.Effective date: June 27, 2018